Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
The current Merck(MRK) stock price is $123.31, with a market capitalization of 305.97B. The stock trades at a price-to-earnings (P/E) ratio of 17.01 and offers a dividend yield of 2.6%.
On 2026-02-28, Merck(MRK) stock moved within a range of $119.15 to $124.00. With shares now at $123.31, the stock is trading +3.5% above its intraday low and -0.6% below the session's peak.
Trading volume for Merck(MRK) stock has reached 17.64M, versus its average volume of 10.33M.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $125.14 and a low of $73.31.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $125.14 and a low of $73.31.
MRK News
In late February 2026, Synthekine announced a collaboration and supply agreement with Merck to test STK-012 alongside Keytruda and chemotherapy in the ongoing g...
Technology Merck Stock, Up 13% In 2026, Ticks Another Box. Is It Now A Buy? Licensing Merck (MRK) stock, which has climbed 13% in 2026, ticked another box Frida...
Merck (MRK) announced results from the final analysis of the pivotal Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, showing that KEYTRUDA, Merck’s anti-PD...
Analyst ratings
61%
of 31 ratingsMore MRK News
If you are wondering whether Merck is still reasonably priced after its run in recent years, this article will walk through what the current share price might b...
Merck Stock Jumps But Reddit Traders Are Getting Cold Feet Quick Read Merck (MRK) faces a December 2028 patent expiration for Keytruda. The drug generates roug...
Advertisement Keytruda patent risk puts Merck (MRK) restructuring in focus Merck (MRK) is splitting its human health business into two units, Oncology and Spe...
Merck (MRK) Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck, announced the U.S. Food and Drug Administrat...
Biotech and Pharma Merck’s New HIV Drug Shows Promise. Its Chief Medical Officer Explains Why Wall Street Should Care. In this article MRK GILD Merck said its e...
Merck (NYSE:MRK) is restructuring its Human Health division into two units: Oncology and Specialty, Pharma & Infectious Diseases. The company has announced new...
RBC Capital initiated coverage of Merck (MRK) with an Outperform rating and $142 price target The firm sees the stock’s investor enthusiasm continuing with near...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.